+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Orthobiologics Market - Global Forecast 2026-2032- Product Image
Orthobiologics Market - Global Forecast 2026-2032- Product Image
Sale

Orthobiologics Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968631
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Orthobiologics Market is projected to reach USD 7.34 Billion in 2026. It is expected to continue growing at a CAGR of 5.91%, reaching USD 10.37 Billion by 2032.

Orthobiologics are biologically derived or biomimetic products used to support bone, cartilage, tendon, ligament, and soft-tissue repair across orthopedic surgery, sports medicine, spine care, trauma, and regenerative medicine. The category includes allografts, demineralized bone matrices, bone graft substitutes, platelet-rich plasma, bone marrow aspirate concentrate, growth factor-based solutions, and scaffold technologies.

Demand for orthobiologics is anchored in verified healthcare fundamentals: the World Health Organization identifies musculoskeletal conditions as a leading contributor to disability worldwide, and global aging, osteoarthritis prevalence, fracture incidence, and rising orthopedic procedure volumes continue to expand the addressable patient pool. At the same time, regulatory scrutiny is increasing, especially for minimally manipulated human cells, tissues, and cellular and tissue-based products, making evidence generation, manufacturing quality, traceability, and clinical outcomes central to competitive advantage.

Transformative Shifts in the Orthobiologics Landscape

The orthobiologics landscape is shifting from procedure-driven adoption toward evidence-based, outcome-focused commercialization. Hospitals, ambulatory surgery centers, and orthopedic specialists are increasingly evaluating products on clinical durability, infection risk, graft handling, reimbursement alignment, and post-operative recovery outcomes rather than novelty alone.

Several structural shifts are reshaping the market. Spinal fusion and trauma applications continue to support demand for bone graft substitutes and allografts, while sports medicine and joint preservation are increasing interest in platelet-rich plasma and cell-concentrate workflows. Regulatory frameworks such as the U.S. FDA’s distinction between Section 361 and Section 351 HCT/Ps and Europe’s Medical Device Regulation are raising the bar for product claims, documentation, clinical evidence, and post-market surveillance. These changes favor manufacturers with strong clinical data, compliant processing, physician education, and robust quality systems.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in orthobiologics rather than a replacement for clinical judgment. AI-enabled imaging analytics can help stratify patients by bone quality, defect size, cartilage loss, fracture pattern, and risk of delayed union. These tools support more precise product selection and can improve alignment between biologic mechanism, surgical technique, and patient biology.

AI also strengthens the commercial and operational foundation of orthobiologics. Machine learning can support donor tissue screening, batch-level quality analytics, inventory planning, adverse-event signal detection, and real-world evidence generation from registries and electronic health records. As regulators and payers demand stronger proof of safety and value, AI-enabled data pipelines can shorten feedback cycles, improve post-market monitoring, and help substantiate differentiated claims with clinically meaningful evidence.

Key Regional Insights

Asia-Pacific is one of the most dynamic orthobiologics regions, supported by aging populations in Japan, China, South Korea, and Australia; expanding orthopedic infrastructure in India and Southeast Asia; and rising procedure volumes for trauma, spine, and joint reconstruction. China and India add scale through large patient populations and increasing private healthcare capacity, while Japan and Australia emphasize clinical quality, reimbursement discipline, and advanced surgical practice. South Korea’s technology-forward hospitals and regenerative medicine interest further strengthen regional adoption potential.

North America remains a high-value region due to established orthopedic procedure volumes, advanced biologics adoption, strong surgeon specialization, and mature tissue banking infrastructure. The United States leads in product innovation, clinical research, and FDA-regulated pathways, while Canada emphasizes regulated adoption within publicly funded care systems. Latin America, led by Brazil and Mexico, is progressing through private hospital networks, sports medicine demand, expanding orthopedic specialization, and medical tourism, although reimbursement variability and uneven access affect uptake.

Europe is shaped by strict regulatory expectations under the Medical Device Regulation, strong national health systems, and specialty orthopedic centers in Germany, France, Italy, Spain, and the United Kingdom. The Middle East, particularly GCC markets, is investing in orthopedic centers of excellence, private healthcare, and medical tourism, supporting demand for trauma, spine, and sports injury solutions. Africa remains underpenetrated but clinically important, with trauma care, infection control, affordability, and access to safe graft materials defining near-term opportunities across public and private care settings.

Key Group Insights

ASEAN demand is supported by expanding private hospitals, medical tourism in Thailand and Malaysia, and Singapore’s role as a clinical, regulatory, and logistics hub. Adoption is strongest where orthopedic subspecialty care, surgeon training, and distributor networks are well developed. GCC markets are benefiting from national healthcare transformation programs, premium hospital investments, and rising demand for sports injury, spine, trauma, and joint procedures.

The European Union is defined by harmonized but demanding regulatory expectations, strong registry culture, and increasing emphasis on real-world evidence, clinical documentation, and post-market surveillance. BRICS markets offer patient scale, domestic manufacturing ambitions, and rising orthopedic access, with China, India, and Brazil particularly important due to hospital modernization, private healthcare expansion, and musculoskeletal disease burden. G7 countries remain central to orthobiologics innovation because of advanced research ecosystems, aging demographics, high orthopedic utilization, and sophisticated reimbursement assessment. NATO markets, while not a healthcare bloc, share defense medicine priorities relevant to trauma repair, reconstructive surgery, limb salvage, and dual-use regenerative technologies.

Key Country Insights

The United States is the largest innovation and commercialization hub, supported by orthopedic procedure volume, FDA-regulated product pathways, leading academic centers, advanced tissue banking, and active sports medicine adoption. Canada offers steady demand through regulated public health systems and evidence-based procurement, while Mexico benefits from private hospitals, cross-border care, and growing orthopedic specialization. Brazil is Latin America’s most influential market, with scale, private healthcare investment, and strong musculoskeletal procedure demand.

In Europe, the United Kingdom combines NHS oversight with private orthopedic care, Germany leads through hospital infrastructure and medtech adoption, France emphasizes clinical governance and reimbursement assessment, Russia presents selective demand amid market access complexity, and Italy and Spain support adoption through spine, trauma, and sports medicine practices. China is expanding through hospital modernization, aging demographics, and domestic innovation; India is driven by trauma burden, affordability needs, orthopedic capacity expansion, and private care growth; Japan’s aging population sustains demand for high-quality orthopedic solutions; Australia benefits from advanced sports medicine, joint care, and regulated clinical practice; and South Korea combines technology-forward hospitals with strong regenerative medicine interest.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically substantiated orthobiologics portfolios, with clear differentiation by indication, mechanism of action, handling profile, and outcomes evidence. Companies should invest in prospective studies, registry participation, and real-world evidence programs that demonstrate union rates, pain reduction, functional recovery, revision avoidance, safety, and cost-effectiveness.

Commercial execution should focus on surgeon education, compliant claims, supply reliability, and payer-aligned value messaging. Manufacturers should strengthen tissue sourcing transparency, biologic processing controls, cold-chain or inventory management where applicable, and post-market surveillance. Partnerships with orthopedic centers, ambulatory surgery networks, AI analytics providers, and regional distributors can accelerate adoption while preserving regulatory compliance and clinical credibility.

Research Methodology

This executive summary is developed using a secondary research approach grounded in publicly available, verifiable sources, including regulatory guidance, national health statistics, scientific literature, hospital procurement trends, clinical registries, and healthcare policy updates. Key reference frameworks include U.S. FDA HCT/P classifications, European Medical Device Regulation requirements, WHO musculoskeletal disease data, national orthopedic utilization indicators, and peer-reviewed evidence on biologic orthopedic interventions.

The methodology emphasizes triangulation across demand drivers, procedure settings, product categories, regulatory pathways, and regional healthcare systems. Insights are validated through consistency checks across clinical, commercial, and policy sources, with preference given to data-backed trends over speculative claims. Market interpretation focuses on adoption readiness, evidence strength, reimbursement feasibility, safety, traceability, and operational scalability.

Conclusion

The orthobiologics market is advancing from early regenerative enthusiasm toward disciplined, evidence-led growth. Aging populations, musculoskeletal disease burden, orthopedic procedure demand, and the pursuit of faster recovery continue to support long-term adoption across spine, trauma, sports medicine, joint preservation, and reconstructive applications.

The strongest opportunities will accrue to organizations that combine scientific credibility, regulatory discipline, manufacturing quality, and clinician trust. As artificial intelligence, real-world evidence, and precision patient selection mature, orthobiologics companies that prove measurable clinical and economic value will be best positioned to lead the next phase of orthopedic innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Orthobiologics Market, by Product Type
7.1. Introduction
7.2. Viscosupplements
7.3. Demineralized Bone Matrix
7.4. Platelet-Rich Plasma
7.4.1. Leukocyte-Rich PRP
7.4.2. Leukocyte-Poor PRP
7.4.3. Pure PRP
7.5. Stem Cell
7.5.1. Hematopoietic
7.5.2. Mesenchymal
7.6. Synthetic Bone Substitutes
7.6.1. Bioactive Glass
7.6.2. Calcium Phosphate
7.6.2.1. Hydroxyapatite
7.6.2.2. Tricalcium Phosphate
7.6.3. Calcium Sulfate
8. Orthobiologics Market, by Source
8.1. Introduction
8.2. Autologous
8.2.1. Bone Marrow
8.2.2. Adipose Tissue
8.3. Allogeneic
8.4. Xenogeneic
8.4.1. Bovine
8.4.2. Porcine
8.5. Synthetic
9. Orthobiologics Market, by Formulation
9.1. Introduction
9.2. Injectable
9.2.1. Liquid
9.2.2. Gel
9.3. Solid
9.3.1. Blocks
9.3.2. Granules
9.3.3. Scaffolds
9.4. Putty
9.5. Paste
10. Orthobiologics Market, by Mechanism of Action
10.1. Introduction
10.2. Osteogenesis
10.3. Osteoinduction
10.4. Osteoconduction
11. Orthobiologics Market, by Application
11.1. Introduction
11.2. Spinal Fusion
11.2.1. Cervical Fusion
11.2.2. Thoracic Fusion
11.2.3. Lumbar Fusion
11.3. Trauma Repair
11.3.1. Upper Extremities
11.3.2. Lower Extremities
11.4. Reconstructive Surgery
11.5. Sports Injuries
11.5.1. Tendon Injuries
11.5.2. Ligament Injuries
11.5.3. Cartilage Repair
11.6. Degenerative Disorders
11.7. Dental Applications
12. Orthobiologics Market, by End User
12.1. Introduction
12.2. Hospitals
12.2.1. Public
12.2.2. Private
12.3. Orthopedic Clinics
12.4. Research & Academic Institutes
12.5. Rehabilitation Centers
13. Orthobiologics Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Orthobiologics Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Orthobiologics Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Orthobiologics Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. Japan
16.5. India
16.6. United Kingdom
16.7. France
16.8. Canada
16.9. Italy
16.10. Australia
16.11. South Korea
16.12. Brazil
16.13. Mexico
16.14. Russia
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. AlloSource
18.2. Alphatec Holdings Inc
18.3. Anika Therapeutics Inc
18.4. Arthrex Inc
18.5. Baxter International Inc
18.6. Bioventus LLC
18.7. Bone Biologics Corporation
18.8. BoneSupport AB
18.9. Cerapedics Inc
18.10. Collagen Matrix Inc
18.11. Globus Medical Inc
18.12. Integra LifeSciences Holdings Corporation
18.13. Isto Biologics
18.14. Johnson & Johnson Services Inc
18.15. Kuros Biosciences AG
18.16. LifeNet Health
18.17. Medtronic plc
18.18. NuVasive Inc
18.19. Organogenesis Holdings Inc
18.20. Orthofix Medical Inc
18.21. RTI Surgical Inc
18.22. Seaspine Holdings Corporation
18.23. Smith & Nephew plc
18.24. Stryker Corporation
18.25. Vericel Corporation
18.26. Xtant Medical Holdings Inc
18.27. Zimmer Biomet Holdings Inc
List of Figures
FIGURE 1. GLOBAL ORTHOBIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ORTHOBIOLOGICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ORTHOBIOLOGICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ORTHOBIOLOGICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ORTHOBIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ORTHOBIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PLATELET-RICH PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LEUKOCYTE-RICH PRP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LEUKOCYTE-POOR PRP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PURE PRP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PURE PRP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PURE PRP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL STEM CELL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STEM CELL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STEM CELL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HEMATOPOIETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HEMATOPOIETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HEMATOPOIETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MESENCHYMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MESENCHYMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MESENCHYMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC BONE SUBSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TRICALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CALCIUM SULFATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CALCIUM SULFATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOLOGOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOLOGOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AUTOLOGOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BONE MARROW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BONE MARROW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BONE MARROW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ADIPOSE TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ALLOGENEIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ALLOGENEIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ALLOGENEIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL XENOGENEIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL XENOGENEIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL XENOGENEIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BOVINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PORCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL GEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL GEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BLOCKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BLOCKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL BLOCKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GRANULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SCAFFOLDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SCAFFOLDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SCAFFOLDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PUTTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PUTTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PUTTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PASTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PASTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL OSTEOGENESIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL OSTEOGENESIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL OSTEOGENESIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL OSTEOINDUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL OSTEOINDUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL OSTEOINDUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL OSTEOCONDUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CERVICAL FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CERVICAL FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CERVICAL FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL THORACIC FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL THORACIC FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL THORACIC FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL LUMBAR FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL LUMBAR FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL LUMBAR FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL TRAUMA REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL TRAUMA REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL TRAUMA REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL UPPER EXTREMITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL LOWER EXTREMITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL RECONSTRUCTIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL SPORTS INJURIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL SPORTS INJURIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL SPORTS INJURIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL TENDON INJURIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL TENDON INJURIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL TENDON INJURIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL LIGAMENT INJURIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL CARTILAGE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL DEGENERATIVE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL DENTAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 202. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 205. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 206. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 207. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 208. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 209. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 210. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 211. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 212. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 213. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 214. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 215. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 217. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 218. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 219. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 221. EUROPE ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 223. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 225. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 226. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 227. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 228. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 229. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 230. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 231. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 232. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 233. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 234. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 235. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 237. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 238. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 239. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 241. NORTH AMERICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 242. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 243. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 244. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 245. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 246. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 247. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 248. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 249. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 250. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 251. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 252. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 253. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 254. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 255. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 257. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 258. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 259. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 261. LATIN AMERICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 263. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 264. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 265. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 266. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 267. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 268. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 269. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 270. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 271. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 272. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 273. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 274. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 275. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 277. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 278. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 279. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 281. AFRICA ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 283. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 285. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 286. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 287. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 288. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 289. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 290. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 291. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 292. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 293. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 294. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 295. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 297. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 298. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 299. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 300. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 301. MIDDLE EAST ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. NATO ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 304. NATO ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 305. NATO ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 306. NATO ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 307. NATO ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 308. NATO ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 309. NATO ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 310. NATO ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 311. NATO ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 312. NATO ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 313. NATO ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 314. NATO ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 315. NATO ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 316. NATO ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. NATO ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 318. NATO ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 319. NATO ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 320. NATO ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. NATO ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 322. NATO ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. G7 ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 324. G7 ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 325. G7 ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 326. G7 ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 327. G7 ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 328. G7 ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 329. G7 ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 330. G7 ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 331. G7 ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 332. G7 ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 333. G7 ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 334. G7 ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 335. G7 ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 336. G7 ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 337. G7 ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 338. G7 ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 339. G7 ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 340. G7 ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 341. G7 ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 342. G7 ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 343. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 344. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 345. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 346. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 347. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 348. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 349. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 350. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 351. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 352. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 353. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 354. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 355. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 356. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 357. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 358. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 359. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 360. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 362. EUROPEAN UNION ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 363. BRICS ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 364. BRICS ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 365. BRICS ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLASMA, 2017-2032 (USD MILLION)
TABLE 366. BRICS ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL, 2017-2032 (USD MILLION)
TABLE 367. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 368. BRICS ORTHOBIOLOGICS MARKET SIZE, BY CALCIUM PHOSPHATE, 2017-2032 (USD MILLION)
TABLE 369. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 370. BRICS ORTHOBIOLOGICS MARKET SIZE, BY AUTOLOGOUS, 2017-2032 (USD MILLION)
TABLE 371. BRICS ORTHOBIOLOGICS MARKET SIZE, BY XENOGENEIC, 2017-2032 (USD MILLION)
TABLE 372. BRICS ORTHOBIOLOGICS MARKET SIZE, BY FORMULATION, 2017-2032 (USD MILLION)
TABLE 373. BRICS ORTHOBIOLOGICS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 374. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SOLID, 2017-2032 (USD MILLION)
TABLE 375. BRICS ORTHOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 376. BRICS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 377. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 378. BRICS ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, 2017-2032 (USD MILLION)
TABLE 379. BRICS ORTHOBIOLOGICS MARKET SIZE, BY SPORTS INJURIES, 2017-2032 (USD MILLION)
TABLE 380. BRICS ORTHOBIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 381. BRICS ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 382. BRICS ORTHOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 383. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 384. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 385. ASEAN ORTHOBIOLOGICS MARKET SIZE, BY PLATELET-RICH PLAS

Companies Mentioned

  • AlloSource
  • Alphatec Holdings Inc
  • Anika Therapeutics Inc
  • Arthrex Inc
  • Baxter International Inc
  • Bioventus LLC
  • Bone Biologics Corporation
  • BoneSupport AB
  • Cerapedics Inc
  • Collagen Matrix Inc
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Isto Biologics
  • Johnson & Johnson Services Inc
  • Kuros Biosciences AG
  • LifeNet Health
  • Medtronic plc
  • NuVasive Inc
  • Organogenesis Holdings Inc
  • Orthofix Medical Inc
  • RTI Surgical Inc
  • Seaspine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Vericel Corporation
  • Xtant Medical Holdings Inc
  • Zimmer Biomet Holdings Inc

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.34 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.37 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Orthobiologics - Global Strategic Business Report - Product Image

Orthobiologics - Global Strategic Business Report

  • Report
  • 233 Pages
  • Global
From
Synthetic Orthobiologics - Global Strategic Business Report - Product Image

Synthetic Orthobiologics - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Orthobiologics Market Report by Product, Type, Application, End User, and Region 2026-2034 - Product Image

Orthobiologics Market Report by Product, Type, Application, End User, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From
Orthobiologics Devices and Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Orthobiologics Devices and Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Orthobiologics Market Report 2026 - Product Image

Orthobiologics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.